An update on conventional and advanced magnetic resonance imaging techniques in the differential diagnosis of neurodegenerative parkinsonism

Purpose of reviewThe clinical differentiation between Parkinson's disease and atypical parkinsonian disorders (APD) remains a challenge for every neurologist. Conventional magnetic resonance imaging (MRI) and different advanced MRI techniques offer the potential for objective criteria in the differential diagnosis of neurodegenerative parkinsonism. The aim of this article is to review the recent literature on the role of conventional and advanced MRI techniques in the differential diagnosis of neurodegenerative parkinsonian disorders. Recent findingsAn important role of MRI is the exclusion of symptomatic parkinsonism due to other pathologies. Over the past two decades, conventional MRI and different advanced MRI techniques, including proton magnetic resonance spectroscopy (1H-MRS), diffusion-weighted imaging (DWI), magnetization transfer imaging (MTI) and magnetic resonance volumetry (MRV) have been found to show abnormalities in the substantia nigra and basal ganglia, especially in APD. Recent studies using MRV, MTI, DWI and 1H-MRS to discriminate Parkinson's disease from APD are discussed extensively. SummaryResearch findings suggest that novel MRI techniques such as MTI, DWI and MRV have superior sensitivity compared to conventional MRI in detecting abnormal features in neurodegenerative parkinsonian disorders. Whether these techniques will emerge as standard investigations in the work-up of patients presenting with parkinsonism requires further prospective magnetic resonance studies during early disease stages.

[1]  I. Saatci,et al.  Cranial MR findings in Wilson's disease , 1997, Acta radiologica.

[2]  I. McKeith,et al.  Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. , 2004, Brain : a journal of neurology.

[3]  B. Drayer,et al.  Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. , 2002, Archives of neurology.

[4]  M. Savoiardo.  Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging , 2003, Neurological Sciences.

[5]  A. Lang,et al.  Parkinson's disease. Second of two parts. , 1998, The New England journal of medicine.

[6]  W. Heiss,et al.  Differentiating multiple system atrophy from Parkinson’s disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging , 2002, Journal of neurology, neurosurgery, and psychiatry.

[7]  H. Watanabe,et al.  Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker. , 2004, Journal of neurology, neurosurgery, and psychiatry.

[8]  Denis Le Bihan,et al.  Looking into the functional architecture of the brain with diffusion MRI , 2003, Nature Reviews Neuroscience.

[9]  Karsten Specht,et al.  In vivo voxel-based morphometry in multiple system atrophy of the cerebellar type. , 2003, Archives of neurology.

[10]  J. O'Brien,et al.  A Comprehensive Review of Proton Magnetic Resonance Spectroscopy Studies in Dementia and Parkinson’s Disease , 2002, Dementia and Geriatric Cognitive Disorders.

[11]  I. Aiba,et al.  Longitudinal MRI study of multiple system atrophy – when do the findings appear, and what is the course? , 2002, Journal of Neurology.

[12]  Wenhua Liu.  Vascular Parkinsonism , 2004 .

[13]  C Kremser,et al.  Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy , 2003, Neurology.

[14]  Alan C. Evans,et al.  Cerebral atrophy and its relation to cognitive impairment in Parkinson disease , 2005, Neurology.

[15]  C. Jack,et al.  Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. , 2004, Archives of neurology.

[16]  Yoav Ben-Shlomo,et al.  The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. , 2002, Brain : a journal of neurology.

[17]  I. McKeith,et al.  SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders , 2003, Movement disorders : official journal of the Movement Disorder Society.

[18]  L Solymosi,et al.  Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. , 2001, Archives of neurology.

[19]  M Hutchinson,et al.  Parkinson's disease: a novel MRI method for determining structural changes in the substantia nigra , 1999, Journal of neurology, neurosurgery, and psychiatry.

[20]  Francesco Federico,et al.  Proton magnetic resonance spectroscopy in parkinson's disease and atypical parkinsonian disorders , 1997 .

[21]  W. Oertel,et al.  [123]IBZM Binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy , 1997, Movement disorders : official journal of the Movement Disorder Society.

[22]  A. Righini,et al.  MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. , 2004, AJNR. American journal of neuroradiology.

[23]  R. Hauser,et al.  Magnetic Resonance Imaging of Corticobasal Degeneration , 1996, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[24]  N P Quinn,et al.  Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. , 1994, Brain : a journal of neurology.

[25]  Nick C. Fox,et al.  Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease , 2004, NeuroImage.

[26]  R I Grossman,et al.  Magnetization transfer histogram methodology: its clinical and neuropsychological correlates. , 1999, Neurology.

[27]  S. Blunt.  Fetal neural graft survival , 1990, The Lancet.

[28]  Vascular parkinsonism. , 2004, Journal of neurology.

[29]  R. Balaban,et al.  Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo , 1989, Magnetic resonance in medicine.

[30]  A J Lees,et al.  Clinical usefulness of magnetic resonance imaging in multiple system atrophy , 1998, Journal of neurology, neurosurgery, and psychiatry.

[31]  C Kremser,et al.  Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD , 2002, Neurology.

[32]  Dorothee P Auer,et al.  T2*-weighted MRI differentiates multiple system atrophy from Parkinson’s disease , 2002, Neurology.

[33]  S. Fahn,et al.  Study of movement disorders and brain iron by MR. , 1987, AJR. American journal of roentgenology.

[34]  E. Ciceri,et al.  Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. , 1994, Journal of neural transmission. Supplementum.

[35]  W. Kamphorst,et al.  Movement disorders with multiple sclerosis. , 1997, Movement disorders : official journal of the Movement Disorder Society.

[36]  Michael Hutchinson,et al.  MRI correlates of pathology in parkinsonism: segmented inversion recovery ratio imaging (SIRRIM) , 2003, NeuroImage.

[37]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[38]  W. Heiss,et al.  The sensitivity of 18‐fluorodopa positron emission tomography and magnetic resonance imaging in Parkinson's disease , 2004, European journal of neurology.

[39]  Dennis Velakoulis,et al.  Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. , 2002 .

[40]  M. Skalej,et al.  Magnetic resonance imaging–based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy , 1999, Annals of neurology.

[41]  G K Wenning,et al.  Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[42]  Werner Jaschke,et al.  Comparison of diffusion‐weighted imaging and [123I]IBZM‐SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.

[43]  A. Lang,et al.  Parkinson's disease. First of two parts. , 1998, The New England journal of medicine.

[44]  Nick C Fox,et al.  Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy , 2005, Neurology.

[45]  F Federico,et al.  Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[46]  W. Oertel,et al.  123I‐IBZM binding compared with long‐term clinical follow up in patients with de novo parkinsonism , 1998, Movement disorders : official journal of the Movement Disorder Society.

[47]  J. Dichgans,et al.  Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[48]  Shigenobu Nakamura,et al.  Magnetization Transfer Measurements of Brain Structures in Patients with Multiple System Atrophy , 2002, NeuroImage.

[49]  L. Deecke,et al.  Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[50]  C. Marsden,et al.  Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy , 1995, Annals of neurology.

[51]  J V Hajnal,et al.  A comparison of (18)F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease. , 2001, Neurology.

[52]  C. Summerfield,et al.  Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. , 2005, Archives of neurology.

[53]  D. Spencer,et al.  Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. , 1992, The New England journal of medicine.

[54]  C. Clarke,et al.  Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes , 2001, European journal of neurology.

[55]  David J. Brooks,et al.  A comparison of 18F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson’s disease , 2001, Neurology.

[56]  P. Boesiger,et al.  In vivo 1H NMR spectroscopy of individual human brain metabolites at moderate field strengths. , 2003, Magnetic resonance imaging.

[57]  H. Hanyu,et al.  Magnetisation transfer measurements of the subcortical grey and white matter in Parkinson's disease with and without dementia and in progressive supranuclear palsy , 2001, Neuroradiology.

[58]  I Litvan,et al.  Progression of Hoehn and Yahr stages in parkinsonian disorders: A clinicopathologic study , 2000, Neurology.

[59]  D Petersen,et al.  Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[60]  Won Yong Lee,et al.  Comparison of magnetic resonance imaging in subtypes of multiple system atrophy. , 2004, Parkinsonism & related disorders.

[61]  D. Radice,et al.  Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy , 1999, Neurology.

[62]  Johannes Dichgans,et al.  Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration , 2004, NeuroImage.

[63]  G. Elbel,et al.  Magnetic resonance imaging findings in corticobasal degeneration , 1999, Movement disorders : official journal of the Movement Disorder Society.

[64]  F. Tison,et al.  Oral zolmitriptan is effective in the acute treatment of cluster headache , 2000, Neurology.

[65]  D. J. Brooks,et al.  Morphological and functional imaging studies on the diagnosis and progression of Parkinson’s disease , 2000, Journal of Neurology.

[66]  I Litvan,et al.  Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[67]  G Di Chiro,et al.  Multiple system atrophy (Shy-Drager syndrome): MR imaging. , 1986, Radiology.

[68]  C Trenkwalder,et al.  The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy? , 1999, Archives of neurology.

[69]  C D Marsden,et al.  Corticobasal degeneration: A clinical study of 36 cases , 1994 .

[70]  Y Nakata,et al.  Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[71]  Y. Abe,et al.  Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. , 2002, Brain : a journal of neurology.

[72]  G A Johnson,et al.  Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron. , 1986, Radiology.

[73]  Mircea Ariel Schoenfeld,et al.  Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging , 2004, NeuroImage.

[74]  Karsten Specht,et al.  Voxel-based analysis of multiple-system atrophy of cerebellar type: complementary results by combining voxel-based morphometry and voxel-based relaxometry , 2005, NeuroImage.

[75]  J. Krauss,et al.  Parkinsonism and rest tremor secondary to supratentorial tumours sparing the basal ganglia , 2005, Acta Neurochirurgica.

[76]  J. Currie,et al.  Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. , 2002, Brain : a journal of neurology.

[77]  Osamu Onodera,et al.  Quantitative evaluation of brainstem involvement in multiple system atrophy by diffusion-weighted MR imaging , 2004, Journal of Neurology.

[78]  B. Manyam,et al.  Bilateral striopallidodentate calcinosis: Cerebrospinal fluid, imaging, and cerebrospinal fluid, imaging, and electrophysiological studies , 1992, Annals of neurology.

[79]  C. Büchel,et al.  Voxel‐based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy , 2003, Movement disorders : official journal of the Movement Disorder Society.

[80]  Christian Kremser,et al.  Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under high-dose methylprednisolone therapy , 2003, NeuroImage.

[81]  A. Righini,et al.  Thin Section MR Study of the Basal Ganglia in the Differential Diagnosis Between Striatonigral Degeneration and Parkinson Disease , 2002, Journal of computer assisted tomography.

[82]  Klaus Seppi,et al.  Progression of parkinsonism in multiple system atrophy , 2005, Journal of Neurology.

[83]  Christian Kremser,et al.  Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease , 2004, NeuroImage.